Carlisle Target Raised After Q4 Results and 4 Stock Analyses Making Rounds
Arctic Cat Inc. (NASDAQ:ACAT): Current price $37.00
KeyBanc said Arctic Cat’s analyst meeting was supportive of their positive thesis. Shares are Buy rated.
Cree Inc. (NASDAQ:CREE): Current price $44.66
DA Davidson increased their price target on Cree, as the firm thinks that improving fundamentals and margins will drive 45% and 30% year-over-year growth in the company’s earnings in 2013 and 2014, respectively. The firm maintains a Buy rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Carlisle Companies Inc. (NYSE:CSL): Current price $66.75
Following fourth quarter results, Baird raised their price target and estimates on Carlisle. The firm cited their solid portfolio, margin improvements, and increased conviction longer-term returns. Shares are Outperform rated.
NewLink Genetics Corp. (NASDAQ:NLNK): Current price $12.52
Citing near term pivotal data from their leading drug candidate and a strengthened balance sheet, Baird believes NewLink Genetics remains well-positioned to outperform their small-cap peers. Shares are Outperform rated with a $20 price target.
Sirona Dental Systems Inc. (NASDAQ:SIRO): Current price $72.82
Following solid first quarter results, Baird raised their price target on Sirona Dental Systems. The firm cited new products, improved margins, and domestic price increases. Shares are Outperform rated.
Don’t Miss: Is Activision Likely to Outperform?